On Apr. 21, 2020, Todos Medical announced that Gnomegen has received Emergency Use Authorization from the FDA for its real-time digital polymerase chain reaction diagnostic test for COVID-19. Gibraltar Brothers, a US-based subsidiary of Shanghai Liangrun Biomedicine, added Gnomegen as a supplier of PCR Test Kits to Todos under Gibraltar’s existing agreements.

This allowed Todos to use the Gnomegen PCR Test Kits for its CLIA laboratory services business, as well as for distribution through Todos’ network.